CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD [Phase 2]

Phase 2 trial evaluating the safety and efficacy of HL231 inhalation solution in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED